During the past decade, Hopital Carémeau - Nîmes conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hopital Carémeau - Nîmes" are "Atrial Fibrillation" (1 trials), "Chronic Kidney Disease" (1 trials), "Neuropathic Pain Associated With Diabetic Peripheral Neuropathy" (1 trials), "Prevention of Stroke or Systemic Embolism" (1 trials) and "Type 2 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "Hopital Carémeau - Nîmes" in a lesser frequency.

Most popular intervention types in "Hopital Carémeau - Nîmes" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials), "Asundexian matching placebo" (1 trials) and "BAY1817080" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Carémeau - Nîmes" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Hopital Carémeau - Nîmes". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Hopital Carémeau - Nîmes, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Carémeau - Nîmes, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".